Latest filing published 07 Mar 2022 for NEPHROS INC, €36k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -81.0%Entry US$7.75 · Close at T+365 US$1.47
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Andrew Astor: trading record in brief
Andrew Astor is a declared insider of Nephros Inc (chief executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 10 April 2018 to 5 March 2022, the count stands at 14 filings.
Purchases make up the whole of the open-market record (10 purchases, €109k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 3 share grants and 1 option exercise.
In size, the median ticket on the buying side is €6,116. 4 out of 8 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The newest entry dates from 7 March 2022: an option exercise of €36k, in Nephros Inc. The most recent open-market purchase was published on 18 August 2021, 1,909 days ago. Most trades are made public on the day they happen. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Andrew Astor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,815 shares@ US$2.7068.8% of flowCommon StockSEC:0001437749-22-005408:0
- 2,500 shares@ US$7.668731.2% of flowCommon StockSEC:0000914190-21-000282:0Canonical exit: 15 Nov 2021 (T+90)
- 1,000 shares@ US$5.86696.1% of flowCommon StockSEC:0000914190-20-000420:0Canonical exit: 17 Feb 2021 (T+90)
- 950 shares@ US$7.406.9% of flowCommon StockSEC:0000914190-20-000331:0Canonical exit: 17 Nov 2020 (T+90)
- 1,000 shares@ US$6.967.3% of flowCommon StockSEC:0000914190-20-000192:0Canonical exit: 26 Aug 2020 (T+90)
- 1,000 shares@ US$6.706.9% of flowCommon StockSEC:0000914190-20-000112:0Canonical exit: 10 Jun 2020 (T+90)
- 700 shares@ US$8.465.5% of flowCommon StockSEC:0000914190-20-000105:0Canonical exit: 3 Jun 2020 (T+90)
- 6,848 shares0Common StockSEC:0000914190-19-000510:0
- 750 shares@ US$8.384.9% of flowCommon StockSEC:0000914190-19-000417:0Canonical exit: 16 Feb 2020 (T+90)
- 1,500 shares@ US$6.976.1% of flowCommon StockSEC:0000914190-19-000337:0Canonical exit: 20 Nov 2019 (T+90)
- 35,000 shares@ US$0.64Common StockSEC:0000914190-19-000213:0Canonical exit: 12 Sept 2019 (T+90)
- 44,111 shares0Common StockSEC:0000914190-18-000570:0
- 33,333 shares@ US$0.30Common StockSEC:0000914190-18-000197:0
- 80,000 shares@ US$0.45Common StockSEC:0000914190-18-000137:0Canonical exit: 9 Jul 2018 (T+90)
14 of 14 declarations
